Bruce Bennett/Getty Images News
Walgreens Boots Alliance, the pharmacy chain operator listed under NASDAQ as WBA, recently revealed that Mary Langowski, a former executive vice president at its competitor CVS Health (CVS), has been chosen to head its U.S. healthcare segment.
Alongside this move, Walgreens Boots (WBA) has also disclosed that Manmohan Mahajan, who has been in the post of the company’s interim CEO since July, will now assume the responsibilities of the executive vice president and global chief financial officer.
Langowski is set to assume the position of executive vice president and president of WBA’s healthcare division in March, taking over from the previous head, John Driscoll, who will transition to a senior advisory role.
Hailing from CVS (CVS), Langowski played a pivotal role in transforming the pharmacy chain into a healthcare company. Her leadership was instrumental in the successful execution of activities that culminated in its $69 billion acquisition of health insurer Aetna in 2018. Langowski joins WBA from Solera Health, where she served as CEO of the value-based technology company.
Commenting on this development, CEO Tim Wentworth expressed, “Today’s announcement solidifies the leadership team that will carry WBA into its future as we look to expand our reach beyond neighborhood pharmacies into the fastest-growing areas of healthcare.”
Wentworth, a former executive at Cigna (CI), assumed the CEO role at WBA in October, succeeding Rosalind Brewer, who departed in August amid concerns over the company’s shift to healthcare.
